Two-in-one drug combining Herceptin with chemotherapy keeps women’s breast cancers at bay 27 Jun 2019 Guiding chemotherapy to a tumour by attaching it to the antibody-based target drug Herceptin (trastuzumab) is effective at treating women with breast cancer who have no other treatment options, a new clinical trial shows. Find out more Show/Hide
Patients with advanced cancer survive 10 years on first targeted cancer wonder drug 19 Aug 2017 A significant minority of patients with advanced and aggressive cancer have survived more than 10 years after treatment with one of the first successful targeted cancer drugs. Find out more Show/Hide
Promising drug target for aggressive ‘triple-negative’ breast cancers identified 24 Oct 2016 Scientists have identified a molecule crucial to the growth of triple-negative breast cancers that they believe could now be targeted by drugs to help treat patients resistant to chemotherapy. Find out more Show/Hide